Bioelectronics: Revolutionizing Cancer Treatment

Transforming cancer treatment through groundbreaking electrical therapy, ONCOELECTRONICS is dedicated to improving lives with innovation and compassion.

Flexible Bioelectronics
Transforming Cancer Care

ONCOELECTRONICS is redefining cancer treatment by combining innovation, compassion, and cutting-edge technology to target tumors with precision and empower patients with new hope for extended, healthier lives.

Innovative Deeptech
Targeting
Aggressive Cancers

We have developed a disruptive technology that will change the way cancer is treated. We implant soft, flexible electrodes into tumours, and use electricity to kill and control cancer. We will extend and improve the quality of patients lives.

Precision Therapy

Target tumors with unparalleled accuracy using advanced electrical stimulation.

Innovative Design

Experience a seamless integration of soft, flexible implants for maximum comfort.

Enhanced Outcomes

Achieve improved patient survival rates with this revolutionary approach.

Revolutionizing Cancer Treatment with Precision

Discover critical data that underscores our innovation and transformative success.

Immunogenic Response

Survival Rate

Our technology has demonstrated a significant improvement in tumor immunogenicity.

Tumor
Reduction

Tumor Reduction

A measurable decrease in tumor size has been observed during preclinical trials.

Oncoelectronics’ team comprises deeptech founders with expertise in innovative medical technology, oncology, and bioengineering, all driven by a shared commitment to revolutionizing cancer treatment.

Alanna Harlton CEO
Chief Executive Officer

Rod O’Connor PhD
Chief Scientific Officer

Martin Bača PhD
Chief Technology Officer

Transforming Cancer Treatment Through Innovation

Join us in the fight against cancer and discover the power of groundbreaking technology.

Revolutionizing Cancer Care
with Precision Medicine

67 Cours Mirabeau

13100 Aix-en-Provence
FRANCE

info@oncoelectronics.com